JRSS — JRSIS HEALTH CARE Income Statement
0.000.00%
Last trade - 00:00
- $5.19m
- $5.16m
- $0.09m
2018 December 31st | 2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 28.4 | 31.5 | 35.7 | 0 | 0.089 |
Cost of Revenue | |||||
Gross Profit | 20.2 | 23.6 | 28.9 | — | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 22.4 | 26.8 | 30.1 | 0.104 | 0.415 |
Operating Profit | 5.99 | 4.67 | 5.59 | -0.104 | -0.326 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.61 | 1.93 | 5.2 | -0.104 | -0.328 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.85 | 1.27 | 3.83 | -0.104 | -0.328 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1.99 | 0.888 | 2.68 | 3.19 | -33.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.99 | 0.888 | 2.68 | 3.19 | -33.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.11 | 0.529 | 1.47 | -0.056 | -0.073 |